The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Thyroid Gland Disorder Treatment-Global Market Insights and Sales Trends 2024
Synopsis
Hormones released by thyroid gland play a crucial role in stimulating metabolism, growth, and calories processing. Globally, thyroid gland disorders such as hypothyroidism, hyperthyroidism, and thyroid nodules affect around 5% to 10% of the population. Hyperthyroidism and hypothyroidism affect majority of the population primarily due to growing incidence of autoimmune diseases such as Grave’s disease and Hashimoto's thyroiditis. Moreover, iodine deficiency is a widespread problem across the globe and is measured as a prime risk factor for the increase in prevalence of thyroid disorders.
The global Thyroid Gland Disorder Treatment market size is expected to reach US$ 2611 million by 2029, growing at a CAGR of 2.6% from 2023 to 2029. The market is mainly driven by the significant applications of Thyroid Gland Disorder Treatment in various end use industries. The expanding demands from the Men and Women, are propelling Thyroid Gland Disorder Treatment market. Hyperthyroidism, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Hypothyroidism segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Thyroid Gland Disorder Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Thyroid Gland Disorder Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Thyroid Gland Disorder Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Thyroid Gland Disorder Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Thyroid Gland Disorder Treatment covered in this report include Abbott, bioMérieux, Danaher, DiaSorin and Siemens Healthineers, etc.
The global Thyroid Gland Disorder Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott
bioMérieux
Danaher
DiaSorin
Siemens Healthineers
Global Thyroid Gland Disorder Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Thyroid Gland Disorder Treatment market, Segment by Type:
Hyperthyroidism
Hypothyroidism
Others
Global Thyroid Gland Disorder Treatment market, by Application
Men
Women
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Thyroid Gland Disorder Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Hormones released by thyroid gland play a crucial role in stimulating metabolism, growth, and calories processing. Globally, thyroid gland disorders such as hypothyroidism, hyperthyroidism, and thyroid nodules affect around 5% to 10% of the population. Hyperthyroidism and hypothyroidism affect majority of the population primarily due to growing incidence of autoimmune diseases such as Grave’s disease and Hashimoto's thyroiditis. Moreover, iodine deficiency is a widespread problem across the globe and is measured as a prime risk factor for the increase in prevalence of thyroid disorders.
The global Thyroid Gland Disorder Treatment market size is expected to reach US$ 2611 million by 2029, growing at a CAGR of 2.6% from 2023 to 2029. The market is mainly driven by the significant applications of Thyroid Gland Disorder Treatment in various end use industries. The expanding demands from the Men and Women, are propelling Thyroid Gland Disorder Treatment market. Hyperthyroidism, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Hypothyroidism segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Thyroid Gland Disorder Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Thyroid Gland Disorder Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Thyroid Gland Disorder Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Thyroid Gland Disorder Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Thyroid Gland Disorder Treatment covered in this report include Abbott, bioMérieux, Danaher, DiaSorin and Siemens Healthineers, etc.
The global Thyroid Gland Disorder Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott
bioMérieux
Danaher
DiaSorin
Siemens Healthineers
Global Thyroid Gland Disorder Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Thyroid Gland Disorder Treatment market, Segment by Type:
Hyperthyroidism
Hypothyroidism
Others
Global Thyroid Gland Disorder Treatment market, by Application
Men
Women
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Thyroid Gland Disorder Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Thyroid Gland Disorder Treatment
1.1 Thyroid Gland Disorder Treatment Market Overview
1.1.1 Thyroid Gland Disorder Treatment Product Scope
1.1.2 Thyroid Gland Disorder Treatment Market Status and Outlook
1.2 Global Thyroid Gland Disorder Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Thyroid Gland Disorder Treatment Market Size by Region (2018-2029)
1.4 Global Thyroid Gland Disorder Treatment Historic Market Size by Region (2018-2023)
1.5 Global Thyroid Gland Disorder Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Thyroid Gland Disorder Treatment Market Size (2018-2029)
1.6.1 North America Thyroid Gland Disorder Treatment Market Size (2018-2029)
1.6.2 Europe Thyroid Gland Disorder Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Thyroid Gland Disorder Treatment Market Size (2018-2029)
1.6.4 Latin America Thyroid Gland Disorder Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Thyroid Gland Disorder Treatment Market Size (2018-2029)
2 Thyroid Gland Disorder Treatment Market by Type
2.1 Introduction
2.1.1 Hyperthyroidism
2.1.2 Hypothyroidism
2.1.3 Others
2.2 Global Thyroid Gland Disorder Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Thyroid Gland Disorder Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Thyroid Gland Disorder Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Thyroid Gland Disorder Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Thyroid Gland Disorder Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Thyroid Gland Disorder Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Thyroid Gland Disorder Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Thyroid Gland Disorder Treatment Revenue Breakdown by Type (2018-2029)
3 Thyroid Gland Disorder Treatment Market Overview by Application
3.1 Introduction
3.1.1 Men
3.1.2 Women
3.2 Global Thyroid Gland Disorder Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Thyroid Gland Disorder Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Thyroid Gland Disorder Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Thyroid Gland Disorder Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Thyroid Gland Disorder Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Thyroid Gland Disorder Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Thyroid Gland Disorder Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Thyroid Gland Disorder Treatment Revenue Breakdown by Application (2018-2029)
4 Thyroid Gland Disorder Treatment Competition Analysis by Players
4.1 Global Thyroid Gland Disorder Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Thyroid Gland Disorder Treatment as of 2022)
4.3 Date of Key Players Enter into Thyroid Gland Disorder Treatment Market
4.4 Global Top Players Thyroid Gland Disorder Treatment Headquarters and Area Served
4.5 Key Players Thyroid Gland Disorder Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Thyroid Gland Disorder Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott
5.1.1 Abbott Profile
5.1.2 Abbott Main Business
5.1.3 Abbott Thyroid Gland Disorder Treatment Products, Services and Solutions
5.1.4 Abbott Thyroid Gland Disorder Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Recent Developments
5.2 bioMérieux
5.2.1 bioMérieux Profile
5.2.2 bioMérieux Main Business
5.2.3 bioMérieux Thyroid Gland Disorder Treatment Products, Services and Solutions
5.2.4 bioMérieux Thyroid Gland Disorder Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 bioMérieux Recent Developments
5.3 Danaher
5.3.1 Danaher Profile
5.3.2 Danaher Main Business
5.3.3 Danaher Thyroid Gland Disorder Treatment Products, Services and Solutions
5.3.4 Danaher Thyroid Gland Disorder Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 DiaSorin Recent Developments
5.4 DiaSorin
5.4.1 DiaSorin Profile
5.4.2 DiaSorin Main Business
5.4.3 DiaSorin Thyroid Gland Disorder Treatment Products, Services and Solutions
5.4.4 DiaSorin Thyroid Gland Disorder Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 DiaSorin Recent Developments
5.5 Siemens Healthineers
5.5.1 Siemens Healthineers Profile
5.5.2 Siemens Healthineers Main Business
5.5.3 Siemens Healthineers Thyroid Gland Disorder Treatment Products, Services and Solutions
5.5.4 Siemens Healthineers Thyroid Gland Disorder Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 Siemens Healthineers Recent Developments
6 North America
6.1 North America Thyroid Gland Disorder Treatment Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Thyroid Gland Disorder Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Thyroid Gland Disorder Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Thyroid Gland Disorder Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Thyroid Gland Disorder Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Thyroid Gland Disorder Treatment Market Dynamics
11.1 Thyroid Gland Disorder Treatment Industry Trends
11.2 Thyroid Gland Disorder Treatment Market Drivers
11.3 Thyroid Gland Disorder Treatment Market Challenges
11.4 Thyroid Gland Disorder Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
